newsfilter
← Latest News
GlobeNewswire·

MediPharm Labs Reports First Quarter 2026 Results Achieving Positive Adjusted EBITDA

Q1 2026 Positive Adjusted EBITDA(1)Net Revenue of $9M with strong gross margins of 37%OPEX decreased 28% in Q1 2026 versus Q4 2025Company is virtually debt free, with a Q1 ending cash balance of $9.9 million and outright